These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

532 related items for PubMed ID: 11566035

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Prophylaxis and therapy of gastropathy caused by non-steroidal anti-inflammatory drugs].
    László A.
    Orv Hetil; 2002 Jul 07; 143(27):1643-8. PubMed ID: 12180001
    [Abstract] [Full Text] [Related]

  • 3. Epidemiology of NSAID-related gastroduodenal mucosal injury.
    Aalykke C, Lauritsen K.
    Best Pract Res Clin Gastroenterol; 2001 Oct 07; 15(5):705-22. PubMed ID: 11566036
    [Abstract] [Full Text] [Related]

  • 4. New NSAIDs and gastroduodenal damage.
    Folco GC.
    Ital J Gastroenterol; 1996 Dec 07; 28 Suppl 4():28-9. PubMed ID: 9032579
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Are COX-2 inhibitors truly able to prevent NSAIDs-associated ulcer?].
    Nishida T, Tsujii M, Tsuji S.
    Nihon Rinsho; 2004 Mar 07; 62(3):561-5. PubMed ID: 15038104
    [Abstract] [Full Text] [Related]

  • 7. The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors.
    Laine L.
    Semin Arthritis Rheum; 2002 Dec 07; 32(3 Suppl 1):25-32. PubMed ID: 12528071
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The multisystem adverse effects of NSAID therapy.
    James DS.
    J Am Osteopath Assoc; 1999 Nov 07; 99(11 Suppl):S1-7. PubMed ID: 10643174
    [Abstract] [Full Text] [Related]

  • 10. Helicobacter pylori infection and the use of NSAIDs.
    Bazzoli F, De Luca L, Graham DY.
    Best Pract Res Clin Gastroenterol; 2001 Oct 07; 15(5):775-85. PubMed ID: 11566040
    [Abstract] [Full Text] [Related]

  • 11. COX-2 inhibitors vs. NSAIDs in gastrointestinal damage and prevention.
    Ballinger A, Smith G.
    Expert Opin Pharmacother; 2001 Jan 07; 2(1):31-40. PubMed ID: 11336566
    [Abstract] [Full Text] [Related]

  • 12. [Effects of NSAIDs on prostaglandin synthesis].
    Watanabe T, Higuchi K, Tominaga K, Uchida T, Fujiwara Y, Arakawa T.
    Nihon Rinsho; 2002 Feb 07; 60 Suppl 2():190-4. PubMed ID: 11979776
    [No Abstract] [Full Text] [Related]

  • 13. COX-1 and COX-2 inhibitors.
    Hawkey CJ.
    Best Pract Res Clin Gastroenterol; 2001 Oct 07; 15(5):801-20. PubMed ID: 11566042
    [Abstract] [Full Text] [Related]

  • 14. [Coxibs: cyclooxygenase-2 inhibitors].
    Turnheim K.
    Wien Klin Wochenschr; 2001 Aug 16; 113(15-16):558-65. PubMed ID: 11571832
    [Abstract] [Full Text] [Related]

  • 15. Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.
    Wolfe F, Anderson J, Burke TA, Arguelles LM, Pettitt D.
    J Rheumatol; 2002 Mar 16; 29(3):467-73. PubMed ID: 11908558
    [Abstract] [Full Text] [Related]

  • 16. Detection and prevention of NSAID-induced enteropathy.
    Davies NM, Saleh JY, Skjodt NM.
    J Pharm Pharm Sci; 2000 Mar 16; 3(1):137-55. PubMed ID: 10954683
    [Abstract] [Full Text] [Related]

  • 17. Physiological mediators in nonsteroidal anti-inflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense and adaptation. Focus on nitric oxide and lipoxins.
    Brzozowski T, Konturek PC, Pajdo R, Ptak-Belowska A, Kwiecien S, Pawlik M, Drozdowicz D, Sliwowski Z, Brzozowski B, Konturek SJ, Pawlik WW.
    J Physiol Pharmacol; 2008 Aug 16; 59 Suppl 2():89-102. PubMed ID: 18812631
    [Abstract] [Full Text] [Related]

  • 18. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
    Rainsford KD, Stetsko PI, Sirko SP, Debski S.
    J Pharm Pharmacol; 2003 May 16; 55(5):661-8. PubMed ID: 12831509
    [Abstract] [Full Text] [Related]

  • 19. Non steroidal anti-inflammatory drugs. Minimising the harm, maximising the benefit.
    Hawkey CJ.
    Ital J Gastroenterol Hepatol; 1998 Feb 16; 30(1):48-9. PubMed ID: 9615265
    [No Abstract] [Full Text] [Related]

  • 20. Nonsteroidal anti-inflammatory drugs may delay the repair of gastric mucosa by suppressing prostaglandin-mediated increase of hepatocyte growth factor production.
    Bamba H, Ota S, Kato A, Matsuzaki F.
    Biochem Biophys Res Commun; 1998 Apr 17; 245(2):567-71. PubMed ID: 9571196
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.